drugset

drugset / Trial / NCT05387148

The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence

NCT05387148 ↗

Phase 2 Unknown 20 enrolled South West Sydney Local Health District Lambert Initiative for Cannabinoid Therapeutics · collab University of Sydney · collab

RandomizedCrossoverDouble-blindTreatment

Summary

The study will explore the psychophysiological and neurobiological and mechanisms of CBD in participants with alcohol use disorder

Timeline

Start: 2022-06
Primary completion: 2023-06
Completion: 2024-06

Publications

Hurzeler TP, Logge W, Watt J, DeMayo MM, Suraev A, McGregor IS, Haber PS, Morley KC. The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial. Contemp Clin Trials Commun. 2024 Aug 13;41:101341. doi: 10.1016/j.conctc.2024.101341. eCollection 2024 Oct.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cannabidiol	Other / unclassified	800 mg	Oral

Indications